BIFERARX folic acid cyanocobalamin iron dextran and heme polypeptide tablet

Land: USA

Sprog: engelsk

Kilde: NLM (National Library of Medicine)

Aktiv bestanddel:

FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)

Tilgængelig fra:

Meda Pharmaceuticals

INN (International Name):

FOLIC ACID

Sammensætning:

FOLIC ACID 1 mg

Recept type:

PRESCRIPTION DRUG

Autorisation status:

unapproved drug other

Produktets egenskaber

BIFERARX- FOLIC ACID, CYANOCOBALAMIN, IRON DEXTRAN AND HEME IRON
POLYPEPTIDE TABLET
MEDA PHARMACEUTICALS
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
BIFERARX
IRON SUPPLEMENT TABLETS
RX ONLY
DESCRIPTION
BiferaRx
is a prescription iron supplement. BiferaRx
is a small oval, film-coated maroon tablet, with
black core, debossed and bisected with “68|85” on one side, and
plain on the other.
EACH BIFERARX TABLET CONTAINS:
VITAMINS
Folic
Acid......................................................................................................1
mg
B
(as
cyanocobalamin)............................................................................25
mcg
MINERALS
Iron
as Polysaccharide Iron
Complex................................................................22mg
as HIP (heme iron polypeptide as Proferrin
- bovine source,
USDA
certified)..........................................................................................6
mg
OTHER INGREDIENTS
Microcrystalline cellulose, dibasic calcium phosphate, crospovidone,
magnesium stearate, silicon
dioxide, resin, coating (polyvinyl alcohol, hypromellose, talc, FD&C
Red # 40 Aluminum Lake,
polyethylene glycol, lecithin, titanium dioxide, FD&C Blue # 2
Aluminum Lake).
INDICATIONS AND USAGE
BiferaRx
is a prescription iron supplement indicated for use in improving the
nutritional status of iron
deficiency.
CONTRAINDICATIONS
This product is contraindicated in patients with a known
hypersensitivity to any of the ingredients.
Hemochromatosis and hemosiderosis are contraindications to iron
therapy.
WARNING: Accidental overdose of iron-containing products is a leading
cause of fatal poisoning in
children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case
of accidental overdose, call a
doctor or poison control center immediately.
PRECAUTIONS
Folic acid when administered as a single agent in doses above 0.1 mg
daily may obscur